ningetinib
Small moleculeexperimental
Clinical trial activity
6 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Feb 8, 2014 (NCT04577703)
Timeline
Indications
Mechanism of action
Tyrosine-protein kinase receptor FLT3 inhibitor
Vascular endothelial growth factor receptor 2 inhibitor
- Hepatocyte growth factor receptorINHIBITOR
MET inhibitor
FLT1 inhibitor
FLT3 inhibitor
- Tyrosine-protein kinase receptor UFOINHIBITOR
AXL inhibitor
MERTK inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C- Mol. weight
- 556.59 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3984441 ↗
Also known as
- ningetinib
- ningetinib
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04992858 | Phase 2 | Aug 27, 2021 | Sunshine Lake Pharma Co., Ltd., Sun Yat-Sen University |
| NCT04601610 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2020 | Alphamab Co., Ltd., People's Liberation Army of China, Sunshine Lake Pharma Co., Ltd. |
| NCT03876925 | Phase 1/Phase 2 (Phase 2) | Jun 14, 2018 | Chinese Academy of Medical Sciences, Sunshine Lake Pharma Co., Ltd. |
| NCT03125876 | Phase 1 | Apr 25, 2017 | Chinese Academy of Medical Sciences, Sunshine Lake Pharma Co., Ltd. |
| NCT03758287 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2016 | Sunshine Lake Pharma Co., Ltd., Sun Yat-Sen University |
| NCT04577703 | Phase 1 | Feb 8, 2014 | Sunshine Lake Pharma Co., Ltd., Sun Yat-Sen University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sunshine Lake Pharma Co., Ltd. | For profit | 6 | 5 | 2 | 2014 |
| Sun Yat-Sen University | Academic/Hospital | 3 | 0 | 2 | 2014 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 2 | 2017 |
| Alphamab Co., Ltd. | For profit | 1 | 1 | 1 | 2020 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2020 |
5 organizations
Page 1 / 1